Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.

Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC, Espinosa G, Gómez-Puerta JA, Monegal A, Guañabens N, Peris P.

Rheumatology (Oxford). 2019 Oct 19. pii: kez464. doi: 10.1093/rheumatology/kez464. [Epub ahead of print]

PMID:
31628810
2.
3.

Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.

Kanterewicz E, Puigoriol E, Rodríguez Cros JR, Peris P.

Osteoporos Int. 2019 Oct;30(10):2141-2149. doi: 10.1007/s00198-019-04962-3. Epub 2019 May 23. Erratum in: Osteoporos Int. 2019 Jul 17;:.

PMID:
31123788
4.

Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone.

Guañabens N, Filella X, Florez H, Ruiz-Gaspá S, Conesa A, Peris P, Monegal A, Torres F.

Bone. 2019 Jul;124:132-136. doi: 10.1016/j.bone.2019.04.023. Epub 2019 Apr 30.

PMID:
31051316
5.

The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Guañabens N, Moro-Álvarez MJ, Casado E, Blanch-Rubió J, Gómez-Alonso C, Díaz-Guerra GM, Del Pino-Montes J, Valero Díaz de Lamadrid C, Peris P, Muñoz-Torres M; SEIOMM Working Group.

Endocrine. 2019 Jun;64(3):441-455. doi: 10.1007/s12020-019-01919-8. Epub 2019 Apr 8. Review.

PMID:
30963388
6.

Imaging Follow-up of SAPHO Syndrome Treated With Zoledronic Acid.

Rodriguez-García SC, Castellanos-Moreira R, Muxí A, Del Amo M, Peris P, Guañabens N.

J Clin Rheumatol. 2019 Mar 12. doi: 10.1097/RHU.0000000000001025. [Epub ahead of print] No abstract available.

PMID:
30870255
7.

Spontaneous vertebral fractures after denosumab discontinuation: A case collection and review of the literature.

Florez H, Ramírez J, Monegal A, Guañabens N, Peris P.

Semin Arthritis Rheum. 2019 Oct;49(2):197-203. doi: 10.1016/j.semarthrit.2019.02.007. Epub 2019 Feb 15.

PMID:
30826108
8.

IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.

Alcolea PJ, Alonso A, Esteban A, Peris P, Cortés A, Castillo JA, Larraga V.

PLoS One. 2019 Feb 22;14(2):e0212136. doi: 10.1371/journal.pone.0212136. eCollection 2019.

9.

Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures.

Peris P, González-Roca E, Rodríguez-García SC, Del Mar López-Cobo M, Monegal A, Guañabens N.

JBMR Plus. 2018 Jun 22;3(1):29-36. doi: 10.1002/jbm4.10064. eCollection 2019 Jan.

10.

Phlebotomine mortality effect of systemic insecticides administered to dogs.

Gomez SA, Curdi JL, Hernandez JAC, Peris PP, Gil AE, Velasquez RVO, Hernandez PO, Picado A.

Parasit Vectors. 2018 Apr 5;11(1):230. doi: 10.1186/s13071-018-2820-x.

11.

Usefulness of the Trabecular Bone Score for assessing the risk of osteoporotic fracture.

Redondo L, Puigoriol E, Rodríguez JR, Peris P, Kanterewicz E.

Rev Clin Esp. 2018 Apr;218(3):121-127. doi: 10.1016/j.rce.2017.12.005. Epub 2018 Jan 9. English, Spanish.

PMID:
29329765
12.

Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.

Florez H, Mandelikova S, Filella X, Monegal A, Guañabens N, Peris P.

Med Clin (Barc). 2018 Jul 23;151(2):65-67. doi: 10.1016/j.medcli.2017.11.036. Epub 2017 Dec 30. English, Spanish.

PMID:
29295788
13.

Cavitating Pulmonary Nodules in a Patient Receiving Anti-TNF.

Martín-de León R, Moisés J, Peris P, Agustí C, Marrades RM.

Arch Bronconeumol. 2018 Aug;54(8):431-432. doi: 10.1016/j.arbres.2017.08.017. Epub 2017 Nov 3. English, Spanish. No abstract available.

14.

Concordance between direct and indirect measurements of free 25-OH vitamin D.

Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat study group.

Clin Chim Acta. 2017 Dec;475:169-171. doi: 10.1016/j.cca.2017.10.016. Epub 2017 Oct 19.

PMID:
29056531
15.

Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.

Gifre L, Humbert L, Muxi A, Del Rio L, Vidal J, Portell E, Monegal A, Guañabens N, Peris P.

Osteoporos Int. 2018 Jan;29(1):201-209. doi: 10.1007/s00198-017-4268-9. Epub 2017 Oct 17.

PMID:
29043391
16.

Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.

Gifre L, Ruiz-Gaspà S, Carrasco JL, Portell E, Vidal J, Muxi A, Monegal A, Guañabens N, Peris P.

Osteoporos Int. 2017 Sep;28(9):2707-2715. doi: 10.1007/s00198-017-4090-4. Epub 2017 Jun 4.

PMID:
28580511
17.

Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study.

Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat Study Group.

Osteoporos Int. 2017 Aug;28(8):2457-2464. doi: 10.1007/s00198-017-4062-8. Epub 2017 May 2.

PMID:
28466136
18.

Is anti-inflammatory radiotherapy an effective treatment in trochanteritis?

Valduvieco I, Biete A, Moreno LA, Gallart X, Rovirosa A, Saez J, Plana C, Peris P.

Br J Radiol. 2017 Jan;90(1069):20160520. doi: 10.1259/bjr.20160520. Epub 2016 Nov 25.

19.

Fibrous dysplasia. Clinical review and therapeutic management.

Florez H, Peris P, Guañabens N.

Med Clin (Barc). 2016 Dec 16;147(12):547-553. doi: 10.1016/j.medcli.2016.07.030. Epub 2016 Oct 17. Review. English, Spanish.

PMID:
27765282
20.

Lack of scintigraphic response of fibrous dysplasia to bisphosphonate treatment.

Florez H, Peris P, Vidal-Sicart S, Monegal A, Guañabens N.

Rheumatology (Oxford). 2016 Oct;55(10):1735. doi: 10.1093/rheumatology/kew284. Epub 2016 Jul 13. No abstract available.

PMID:
27411478
21.

Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.

Guañabens N, Ruiz-Gaspà S, Gifre L, Miquel R, Peris P, Monegal A, Dubrueil M, Arias A, Parés A.

J Bone Miner Res. 2016 Sep;31(9):1725-33. doi: 10.1002/jbmr.2845. Epub 2016 Apr 22.

22.

Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment.

Monegal A, Peris P, Alsina M, Colmenero J, Guañabens N.

Osteoporos Int. 2016 Aug;27(8):2631-4. doi: 10.1007/s00198-016-3571-1. Epub 2016 Mar 24.

PMID:
27010647
23.

Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.

Gifre L, Vidal J, Carrasco JL, Muxi A, Portell E, Monegal A, Guañabens N, Peris P.

Osteoporos Int. 2016 Jan;27(1):405-10. doi: 10.1007/s00198-015-3333-5. Epub 2015 Sep 30.

PMID:
26423406
24.

Invasive Mycobacterium marinum infection.

Plana-Veret C, Iranzo-Fernández P, Peris P, Monegal A, Guañabens N.

Joint Bone Spine. 2015 Dec;82(6):462. doi: 10.1016/j.jbspin.2014.12.015. Epub 2015 Jul 14. No abstract available.

PMID:
26184528
25.

Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.

Gifre L, Vidal J, Carrasco JL, Muxi A, Portell E, Monegal A, Guañabens N, Peris P.

Osteoporos Int. 2015 Sep;26(9):2273-80. doi: 10.1007/s00198-015-3150-x. Epub 2015 May 5.

PMID:
25939310
26.

[Reply].

Gifre L, Peris P.

Med Clin (Barc). 2015 May 21;144(10):477. doi: 10.1016/j.medcli.2014.10.005. Epub 2014 Dec 29. Spanish. No abstract available.

PMID:
25554427
27.

Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment.

Peris P, Blasco J, Carrasco JL, Martinez-Ferrer A, Macho J, San Román L, Monegal A, Guañabens N.

Calcif Tissue Int. 2015 Feb;96(2):89-96. doi: 10.1007/s00223-014-9940-x. Epub 2014 Dec 10.

PMID:
25492165
28.

Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study.

Gifre L, Vidal J, Carrasco JL, Filella X, Ruiz-Gaspà S, Muxi A, Portell E, Monegal A, Guañabens N, Peris P.

J Bone Miner Res. 2015 Jun;30(6):1014-21. doi: 10.1002/jbmr.2423.

29.

Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.

Ruiz-Gaspà S, Dubreuil M, Guañabens N, Combalia A, Peris P, Monegal A, Parés A.

Eur J Clin Invest. 2014 Dec;44(12):1206-14. doi: 10.1111/eci.12355. Epub 2014 Nov 9.

PMID:
25331234
30.

Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis.

Peris P, Roforth MM, Nicks KM, Fraser D, Fujita K, Jilka RL, Khosla S, McGregor U.

J Cell Biochem. 2015 Jan;116(1):58-66. doi: 10.1002/jcb.24942.

31.

[Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia].

Gifre L, Martínez de Osaba MJ, Monegal A, Guañabens N, Peris P.

Med Clin (Barc). 2014 May 20;142(10):447-50. doi: 10.1016/j.medcli.2013.10.030. Epub 2014 Mar 13. Spanish.

PMID:
24629692
32.

Prevalence of vertebral fractures and minor vertebral deformities evaluated by DXA-assisted vertebral fracture assessment (VFA) in a population-based study of postmenopausal women: the FRODOS study.

Kanterewicz E, Puigoriol E, García-Barrionuevo J, del Rio L, Casellas M, Peris P; Frodos Research Group.

Osteoporos Int. 2014 May;25(5):1455-64. doi: 10.1007/s00198-014-2628-2. Epub 2014 Mar 6.

PMID:
24599272
33.

The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis.

Guañabens N, Gifre L, Peris P.

Curr Osteoporos Rep. 2014 Mar;12(1):90-7. doi: 10.1007/s11914-014-0197-0. Review.

PMID:
24488619
34.

High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.

Gómez-Puerta JA, Peris P, Reverter JC, Espinosa G, Martinez-Ferrer A, Monegal A, Monteagudo J, Tàssies D, Guañabens N.

Medicine (Baltimore). 2013 Nov;92(6):295-304. doi: 10.1097/MD.0000000000000007. Review.

35.

Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters.

Guañabens N, Mumm S, Möller I, González-Roca E, Peris P, Demertzis JL, Whyte MP.

J Bone Miner Res. 2014 Apr;29(4):929-34. doi: 10.1002/jbmr.2110.

36.

Incidence of skeletal fractures after traumatic spinal cord injury: a 10-year follow-up study.

Gifre L, Vidal J, Carrasco J, Portell E, Puig J, Monegal A, Guañabens N, Peris P.

Clin Rehabil. 2014 Apr;28(4):361-9. doi: 10.1177/0269215513501905. Epub 2013 Oct 4.

PMID:
24096543
37.

Bone disease in patients awaiting liver transplantation. Has the situation improved in the last two decades?

Monegal A, Navasa M, Peris P, Colmenero J, Cuervo A, Muxí A, Gifre L, Guañabens N.

Calcif Tissue Int. 2013 Dec;93(6):571-6. doi: 10.1007/s00223-013-9797-4. Epub 2013 Sep 25.

PMID:
24065305
38.

Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover.

Gifre L, Ruiz-Gaspà S, Monegal A, Nomdedeu B, Filella X, Guañabens N, Peris P.

Bone. 2013 Nov;57(1):272-6. doi: 10.1016/j.bone.2013.08.016. Epub 2013 Aug 24.

PMID:
23981659
39.

Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.

Guañabens N, Monegal A, Cerdá D, Muxí Á, Gifre L, Peris P, Parés A.

Hepatology. 2013 Dec;58(6):2070-8. doi: 10.1002/hep.26466. Epub 2013 Oct 29.

PMID:
23686738
40.

Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.

Dubreuil M, Ruiz-Gaspà S, Guañabens N, Peris P, Alvarez L, Monegal A, Combalia A, Parés A.

Liver Int. 2013 Aug;33(7):1029-38. doi: 10.1111/liv.12153. Epub 2013 Apr 7.

PMID:
23560764
41.

Risk factors for the development of vertebral fractures after percutaneous vertebroplasty.

Martinez-Ferrer A, Blasco J, Carrasco JL, Macho JM, Román LS, López A, Monegal A, Guañabens N, Peris P.

J Bone Miner Res. 2013 Aug;28(8):1821-9. doi: 10.1002/jbmr.1899.

42.

Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women.

Peris P, Atkinson EJ, Gössl M, Kane TL, McCready LK, Lerman A, Khosla S, McGregor UI.

Mayo Clin Proc. 2013 Jan;88(1):46-55. doi: 10.1016/j.mayocp.2012.08.019. Epub 2012 Dec 8.

43.

Distribution of serum βCTX in a population-based study of postmenopausal women taking into account different anti-osteoporotic therapies (the FRODOS Cohort).

Kanterewicz E, Peris P, Puigoriol E, Yáñez A, Rosique P, Del Rio L; FRODOS Research Group.

J Bone Miner Metab. 2013 Mar;31(2):231-9. doi: 10.1007/s00774-012-0410-0. Epub 2012 Dec 8.

PMID:
23223942
44.

[Effectiveness of vertebroplasty in painful chronic osteoporotic vertebral fractures. A report of 5 patients].

Martínez-Ferrer A, Blasco J, Guañabens N, Pomés J, Peris P.

Med Clin (Barc). 2013 Feb 2;140(3):115-8. doi: 10.1016/j.medcli.2012.07.027. Epub 2012 Nov 28. Spanish.

PMID:
23199828
45.

Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12-month randomized follow-up, controlled trial.

Blasco J, Martinez-Ferrer A, Macho J, San Roman L, Pomés J, Carrasco J, Monegal A, Guañabens N, Peris P.

J Bone Miner Res. 2012 May;27(5):1159-66. doi: 10.1002/jbmr.1564.

46.

25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis.

Peris P, Martínez-Ferrer A, Monegal A, Martínez de Osaba MJ, Muxi A, Guañabens N.

Bone. 2012 Jul;51(1):54-8. doi: 10.1016/j.bone.2012.03.026. Epub 2012 Apr 1.

PMID:
22487299
47.

[Identification of clinical features and laboratory abnormalities associated with the development of vertebral fractures in women with postmenopausal osteoporosis].

Cerdà D, Peris P, Monegal A, Albaladejo C, Surís X, Guañabens N.

Med Clin (Barc). 2012 Dec 8;139(14):626-30. doi: 10.1016/j.medcli.2011.11.033. Epub 2012 Mar 28. Spanish.

PMID:
22459575
49.

Morphometric X-ray absorptiometry (MXA) vertebral heights in Spanish women.

Kanterewicz E, del Rio L, García-Barrionuevo JM, Peris P, Puigoriol E.

Bone. 2012 Apr;50(4):1019-20; author reply 1021. doi: 10.1016/j.bone.2012.01.014. Epub 2012 Jan 28. No abstract available.

PMID:
22306926
50.

[2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis].

Pérez Edo L, Alonso Ruiz A, Roig Vilaseca D, García Vadillo A, Guañabens Gay N, Peris P, Torrijos Eslava A, Beltrán Audera C, Fiter Aresté J, Arboleya Rodríguez L, Graña Gil J, Carbonell Abelló J, Nolla JM, Holgado Pérez S, Salas Heredia E, Zubieta Tabernero J, Del Pino Montes J, Blanch i Rubió J, Caamaño Freire M, Rodríguez Pérez M, Castañeda S, Cerdá D, Gómez Vaquero C, Calvo Catalá J, Ciria M, Loza E; Spanish Society of Rheumatology.

Reumatol Clin. 2011 Nov-Dec;7(6):357-79. doi: 10.1016/j.reuma.2011.05.013. Epub 2011 Sep 15. Spanish.

Supplemental Content

Support Center